Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists

Published:2024-08 Issue: Volume:199 Page:106818
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Chenxu Zhou,Lidan Sun^ORCID,Guoqiang Hu,Binbin Gong,Ting Wang,Xiaoyi Sun,Qian Long

Publisher

Elsevier BV

Reference32 articles.

1. New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454;Bellier;Naunyn Schmiedebergs Arch. Pharmacol.,2004

2. Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men;Brennan;Am.J. Physiol.Regulat., Integrat. Comparat. Physiol.,2005

3. The epidemiology of obesity;Chooi;Metabolism.,2019

4. Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs;Christoffersen;Int. J. Obes.,2020

5. Mechanisms of action and therapeutic application of glucagon-like peptide-1;Drucker;Cell Metab.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP